- Home
- ALIT vs ANIP Comparison
ALIT vs ANIP Comparison
Compare ALIT & ANIP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALIT
- ANIP
- Stock Information
- Founded
- ALIT 2017
- ANIP 2001
- Country
- ALIT United States
- ANIP United States
- Employees
- ALIT N/A
- ANIP N/A
- Industry
- ALIT Business Services
- ANIP Biotechnology: Pharmaceutical Preparations
- Sector
- ALIT Consumer Discretionary
- ANIP Health Care
- Exchange
- ALIT Nasdaq
- ANIP Nasdaq
- Market Cap
- ALIT 1.7B
- ANIP 2.0B
- IPO Year
- ALIT N/A
- ANIP N/A
- Fundamental
- Price
- ALIT $3.00
- ANIP $90.43
- Analyst Decision
- ALIT Strong Buy
- ANIP Strong Buy
- Analyst Count
- ALIT 6
- ANIP 7
- Target Price
- ALIT $8.75
- ANIP $99.14
- AVG Volume (30 Days)
- ALIT 8.5M
- ANIP 290.1K
- Earning Date
- ALIT 11-11-2025
- ANIP 11-07-2025
- Dividend Yield
- ALIT 5.20%
- ANIP N/A
- EPS Growth
- ALIT N/A
- ANIP N/A
- EPS
- ALIT N/A
- ANIP N/A
- Revenue
- ALIT $2,311,000,000.00
- ANIP $747,399,000.00
- Revenue This Year
- ALIT $0.99
- ANIP $39.51
- Revenue Next Year
- ALIT $3.01
- ANIP $9.58
- P/E Ratio
- ALIT N/A
- ANIP N/A
- Revenue Growth
- ALIT N/A
- ANIP 38.68
- 52 Week Low
- ALIT $2.98
- ANIP $52.50
- 52 Week High
- ALIT $8.93
- ANIP $99.50
- Technical
- Relative Strength Index (RSI)
- ALIT 29.05
- ANIP 45.62
- Support Level
- ALIT $2.98
- ANIP $87.60
- Resistance Level
- ALIT $3.39
- ANIP $92.56
- Average True Range (ATR)
- ALIT 0.12
- ANIP 2.27
- MACD
- ALIT 0.02
- ANIP -0.60
- Stochastic Oscillator
- ALIT 8.64
- ANIP 32.73
About ALIT Alight Inc.
Alight Inc is a technology-enabled services company delivering human capital management solutions to many of complex organizations. This includes the implementation and administration of employee benefits (e.g., health, wealth and leaves benefits) solutions, currently operates under one reportable segment, Employer Solutions. The Company completed the Divestiture of Alight's Professional Services segment and Alight's Payroll & HCM Outsourcing business within the Employer Solutions segment. The company operates in USA states and International market too.
About ANIP ANI Pharmaceuticals Inc.
ANI Pharmaceuticals Inc develops, manufactures, and markets generic prescription pharmaceuticals. It manufactures liquid, powder, and oral solid-dose products. Its areas of product development include narcotics, oncolytics, hormones and steroids, and complex formulations involving extended-release and combination products. Some of its generic products include Erythromycin ethyl succinate, Esterified Estrogen with Methyltestosterone (EEMT), Etodolac Fenofibrate, Fluvoxamine, Hydrocortisone Enema and Vancomycin. The company operates in two segments which include Rare Diseases and Brands, Generics, and Others. Its geographical segments are the United States and Canada, of which the majority of its revenue comes from the United States.